Accera Inc, the Singapore-headquartered pharmaceutical company, has announced the first close of its $50 million-investment round led by Wilmar Ventures, a wholly-owned subsidiary of Wilmar International Ltd.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
